$MYGN MYRIAD GENETICS INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MYRIAD GENETICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in MYRIAD GENETICS INC for free.
IRS Number: 870494517
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: MYGN
Company Address: 320 WAKARA WAY SALT LAKE CITY 84108
Phone number: 801-584-3600
Market Capitalization: $1.13B
Prev close: $15.40
Average Daily Volume: 1,118,500
Days Low: $16.34
Year Low: $15.15
Year High: $39.74
MYRIAD GENETICS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 12,848 | 0 | 79,527 | 66.7 K to 79.5 K (+19.27 %) |
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 12,848 | 0 | 89,527 | 76.7 K to 89.5 K (+16.76 %) |
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 12,848 | 0 | 83,527 | 70.7 K to 83.5 K (+18.18 %) |
| May 28 2021 | MYGN | MYRIAD GENETICS IN ... | SPIEGELMAN DANIEL K | Director | Sell | D | 0.00 | 15,889 | 0 | 20,562 | 36.5 K to 20.6 K (-43.59 %) |
| May 05 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 19.47 | 19,360 | 376,939 | 68,640 | |
| May 05 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 31.97 | 19,360 | 618,949 | 265,922 | 285.3 K to 265.9 K (-6.79 %) |
| May 05 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 19.47 | 19,360 | 376,939 | 285,282 | 265.9 K to 285.3 K (+7.28 %) |
| Apr 28 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 19.47 | 40,000 | 778,800 | 88,000 | |
| Apr 28 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 31.47 | 40,000 | 1,258,800 | 265,922 | 305.9 K to 265.9 K (-13.08 %) |
| Apr 28 2021 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 19.47 | 40,000 | 778,800 | 305,922 | 265.9 K to 305.9 K (+15.04 %) |
| Apr 20 2021 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | See Remarks | Sell | S | 27.01 | 5,890 | 159,086 | 129,119 | 135 K to 129.1 K (-4.36 %) |
| Apr 20 2021 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | See Remarks | Sell | S | 27.01 | 759 | 20,500 | 135,009 | 135.8 K to 135 K (-0.56 %) |
| Apr 02 2021 | MYGN | MYRIAD GENETICS IN ... | Santa Eric | Chief Growth Office ... | Grant | A | 0.00 | 16,420 | 0 | 16,420 | 0 to 16.4 K |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 24.89 | 21,966 | 546,734 | 0 | |
| Mar 30 2021 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Chief People Office ... | Option Exercise | M | 19.47 | 28,000 | 545,160 | 0 |